RDNT:NSD-RadNet Inc. (USD)

EQUITY | Diagnostics & Research | NASDAQ Global Market

Last Closing

USD 58.24

Change

+1.51 (+2.66)%

Market Cap

USD 0.29B

Volume

0.36M

Analyst Target

USD 21.67
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

RadNet Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, and among others.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-15 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
IDXX IDEXX Laboratories Inc

+3.25 (+0.73%)

USD 37.69B
ICLR ICON PLC

-4.51 (-1.94%)

USD 23.48B
ILMN Illumina Inc

+1.66 (+1.14%)

USD 22.77B
NTRA Natera Inc

+1.99 (+1.60%)

USD 14.84B
EXAS EXACT Sciences Corporation

+0.82 (+1.18%)

USD 12.84B
MEDP Medpace Holdings Inc

-11.41 (-3.46%)

USD 10.15B
SHC Sotera Health Co

-0.09 (-0.57%)

USD 4.39B
NEOG Neogen Corporation

+0.23 (+1.60%)

USD 2.98B
GH Guardant Health Inc

+1.28 (+5.87%)

USD 2.52B
VCYT Veracyte Inc

+0.62 (+1.80%)

USD 2.50B

ETFs Containing RDNT

PSCH Invesco S&P SmallCap Heal.. 0.00 % 0.29 %

-0.49 (-1.35%)

USD 0.19B
WMCR 0.00 % 0.50 %

N/A

N/A
XHS SPDR® S&P Health Care Se.. 0.00 % 0.35 %

-1.28 (-1.35%)

USD 0.08B

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange (NASDAQ Global Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 67.50% 96% N/A 93% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 67.50% 96% N/A 93% A
Trailing 12 Months  
Capital Gain 109.27% 92% A 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 109.27% 92% A 95% A
Trailing 5 Years  
Capital Gain 343.56% 93% A 94% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 343.56% 93% A 94% A
Average Annual (5 Year Horizon)  
Capital Gain 33.02% 78% C+ 86% B+
Dividend Return 33.02% 78% C+ 86% B+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 51.37% 51% F 32% F
Risk Adjusted Return 64.27% 93% A 88% B+
Market Capitalization 0.29B 88% B+ 87% B+

Key Financial Ratios

  Ratio vs. Industry/Classification (Diagnostics & Research) Ratio vs. Market (NASDAQ Global Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 61.00 11% 8%
Price/Book Ratio 5.67 20% 20%
Price / Cash Flow Ratio 18.98 18% 15%
Price/Free Cash Flow Ratio 16.14 12% 16%
Management Effectiveness  
Return on Equity 6.37% 91% 69%
Return on Invested Capital 6.39% 91% 72%
Return on Assets 2.35% 91% 76%
Debt to Equity Ratio 128.76% 33% 18%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector